Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide-co-glycolide) sintered microsphere scaffolds for bone tissue engineering

Biotechnology and Bioengineering

Volumn 98, Issue 5, 2007, Pages 1094-1102

  Jabbarzadeh, Ehsan ^a   Jiang, Tao ^b   Deng, Meng ^b   Nair, Lakshmi S ^a   Khan, Yusuf M ^a,c   Laurencin, Cato T ^a,b,c  

^a UNIVERSITY OF VIRGINIA   (United States)

^b University of Virginia   (United States)

^c University of Virginia   (United States)

Author keywords

Angiogenesis; Bone; Endothelial cell; Poly(lactide co glycolide); Tissue engineering

Indexed keywords

BONE; CELL GROWTH; COPOLYMERS; ENDOTHELIAL CELLS; POLYESTERS; SCAFFOLDS;

ANGIOGENESIS; BONE TISSUE ENGINEERING; POLY(LACTIDE-CO-GLYCOLIDE);

TISSUE ENGINEERING;

ACTIN; CD31 ANTIGEN; MICROSPHERE; POLYGLACTIN;

ANGIOGENESIS; ARTICLE; CELL ADHESION; CELL CONTACT; CELL COUNT; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; PHENOTYPE; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ACTINS; ANTIGENS, CD31; BONE AND BONES; CELL ADHESION; CELL PROLIFERATION; CELL SURVIVAL; E-SELECTIN; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; POLYGLACTIN 910; POLYSTYRENES; TISSUE ENGINEERING; TISSUE SCAFFOLDS; UMBILICAL VEINS; VON WILLEBRAND FACTOR;

EID: 36749010785     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.21495     Document Type: Article

References (41)

1. 2 films on Ti surfaces for bone-tissue implants. J Biomed Mater Res 57:588-596.
2. Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson JD. 1991. Molecular biology of the cell. New York, NY: Garland Publishing.
3. Borden M, Attawia M, Laurencin CT. 2002a. The sintered microsphere matrix for bone tissue engineering: In vitro osteoconductivity studies. J Biomed Mater Res 61:421-429.
4. Borden M, Attawia M, Khan Y, Laurencin CT. 2002b. Tissue engineered microsphere-based matrices for bone repair: Design and evaluation. Biomaterials 23:551-559.
5. Borden M, El-Amin SF, Attawia M, Laurencin CT. 2003. Structural and human cellular assessment of novel microsphere-based tissue engineered scaffold for bone repair. Biomaterials 24:597-609.
6. Borden M, Attawia M, Khan Y, El-Amin SF, Laurencin CT. 2004. Tissue-engineered bone formation in vivo using a novel sintered polymeric microsphere matrix. J Bone Joint Surg 86B:1200-1208.
7. Bose S, Darsell J, Kintner M, Hosick H, Bandyopadhyay A. 2003. Pore size and pore volume effects on alumina TCP ceramic scaffolds. Mater Sci Eng C23:479-486.
8. Bouhadir KH, Mooney DJ. 2001. Promoting angiogenesis in engineered tissues. J Drug Target 9:397-406.
9. Burg KJL, Porter S, Kellam JF. 2000. Biomaterial developments for bone tissue engineering. Biomaterials 21:2347-2359.
10. Cao GY, O'Brien CD, Zhou Z, Sanders SM, Greenbaum JN, Makrigiannakis A, DeLisser HM. 2002. Involvement of human PECAM-1 in angiogenesis and in vitro endothelial cell migration. Am J Physiol 282:0181-C1190.
11. Colton CK. 1995. Implantable biohybrid artificial organs. Cell Transplant 4:415-436.
12. Cukierman E, Pankov R, Stevens DR, Yamada KY. 2001. Taking cell-matrix adhesions to the third dimension. Science 294:1708-1712.
13. DeLisser HM, Christofidou-Solomidou M, Strieter RM, Burdick MD, Robinson CS, Wexler RS, Kerr JS, Garlanda C, Merwin JR, Madri JA, Albelda SM. 1997. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-677.
14. Folkman J. 1976. The vascularization of tumors. Sci Am 234:58-64.
15. Freshney RI. 1994. Culture of animal cells: A manual of basic techniques. New York, NY: Wiley and Sons Ltd.
16. Halliday NL, Tomasek JJ. 1995. Mechanical properties of the extracellular matrix influence fibronectin fibril assembly in vitro. Exp Cell Res 217: 109-117.
17. Holder WD, Gruber HE, Roland WD, Moore AL, Culberson CR, Loebsack AB, Burg KJL, Mooney DJ. 1997. Increased vascularization and heterogeneity of vascular structure occurring in polyglycolide matrices containing aortic endothelial cells implanted in the rat. Tissue Eng 3:149-160.
18. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. 2003. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114:33-45.
19. Ilan N, Madri JA. 2003. PECAM-1: Old friend, new partners. Curr Opin Cell Biol 15:515-524.
20. Jackson DE. 2003. The unfolding tale of PECAM-1. FEBS Lett 540:7-14.
21. Jiang T, Abdel-Fattah WI, Laurencin CT. 2006. In vitro evaluation of chitosan/poly(lactide acid-glycolide acid) sintered microsphere scaffolds for bone tissue engineering. Biomaterials 27:4894-4903.
22. Kaigler D, Wang Z, Horger K, Mooney DJ, Krebsbach PH. 2006. VEGF scaffolds enhance angiogenesis and bone regeneration in irradiated osseous defects. J Bone Min Res 21:735-744.
23. Kevil CG, Orr AW, Langston W, Mickett K, Murphy-Ullrich J, Patel RP, Kucik DF, Bullard CD. 2004. Intercellular adhesion molecule-1 (ICAM-1) regulates endothelial cell motility through a nitric oxide-dependent pathway. J Biol Chem 279:19230-19238.
24. Kidd KR, Nagle RB, Williams SK. 2002. Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. J Biomed Mater Res 59:366-377.
25. Langer R, Tirrell DA. 2004. Designing materials for biology and medicine. Nature 428:487-492.
26. Langer R, Vacanti JP. 1993. Tissue engineering. Science 260:920-926.
27. Laurencin CT, Ambrosio AMA, Borden MD, Cooper JA. 1990. Tissue engineering orthopedic applications. Ann Rev Biomed Eng 1:19-46.
28. Mantzaris N, Webb S, Othmer HG. 2004. Mathematical modeling of tumor-induced angiogenesis. J Math Biol 49:111-187.
29. Miot S, Woodfield T, Daniels AU, Suetterlin R, Peterschmitt I, Heberer M, van Blitterswijk CA, Riesle J, Martin I. 2005. Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials 26:2479-2489.
30. Newman PJ. 1997. The biology of PECAM-1. J Clin Invest 99:3-7.
31. Patel ZS, Mikos AG. 2004. Angiogenesis with biomaterial-based drug- and cell-delivery systems. J Biomater Sci Polymer Edn 15:701-726.
32. Perets A, Baruch Y, Weisbuch F, Shoshany G, Neufeld G, Cohen S. 2003. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres. J Biomed Mater Res 65:489-497.
33. Peters MC, Polverini PJ, Mooney DJ. 2002. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res 60:668-678.
34. Ratner BD. 2002. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Rel 78:211-218.
35. Sharkawy AA, Kiltzman B, Truskey GA, Reichert WM. 1998. Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J Biomed Mater Res 40:598-605.
36. Sheridan MH, Shea LD, Peters MC, Mooney DJ. 2002. Bioadsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. J Control Rel 64:91-102.
37. Tabata Y, Miyao M, Yamamoto M, Ikada Y. 1999. Vascularization into a porous sponge by sustained release of basic fibroblast growth factor. J Biomater Sci Polymer Edn 10:957-968.
38. Takahashi Y, Tabata Y. 2004. Effect of the fiber diameter and porosity of non-woven PET fabrics on the osteogenic differentiation of mesenchymal stem cells. J Biomater Sci Ed 15:41-57.
39. Wake MC, Patrick CW, Mikos AG. 1994. Pore morphology effects on the fibrovascular tissue-growth in porous polymer substrates. Cell Transplant 3:339-343.
40. Wu X, Rabkin-Aikawa E, Guleserian KJ, Perry TE, Masuda Y, Sutherland FWH, Schoen FJ, Mayer JE, Bischoff J. 2004. Tissue-engineered microvessels on three-dimensional biodegradable scaffolds using human endothelial progenitor cells. Am J Physiol Heart Circ Physiol 287:H480-H487.
41. Zigmond SH. 1996. Signal transduction and actin filament organization. Curr Opin Cell Biol 8:66-73.